APA (7th ed.) Citation

P, I., M, P., A, C., L, F., J, G., J, N., . . . L, S. (2025). Why and how citrate may sensitize malignant tumors to immunotherapy. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 78, 101177. https://doi.org/10.1016/j.drup.2024.101177

Chicago Style (17th ed.) Citation

P, Icard, et al. "Why and How Citrate May Sensitize Malignant Tumors to Immunotherapy." Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy 78 (2025): 101177. https://doi.org/10.1016/j.drup.2024.101177.

MLA (9th ed.) Citation

P, Icard, et al. "Why and How Citrate May Sensitize Malignant Tumors to Immunotherapy." Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy, vol. 78, 2025, p. 101177, https://doi.org/10.1016/j.drup.2024.101177.